Cargando…
Cancer biomarkers : the promises and challenges of improving detection and treatment /
Many cancer patients are diagnosed at a stage in which the cancer is too far advanced to be cured, and most cancer treatments are effective in only a minority of patients undergoing therapy. Thus, there is tremendous opportunity to improve the outcome for people with cancer by enhancing detection an...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Washington, D.C. :
National Academies Press,
©2007.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn182530367 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 070123s2007 dcua ob 000 0 eng d | ||
| 010 | |a 2007921549 | ||
| 040 | |a COCUF |b eng |e pn |c COCUF |d BTCTA |d BAKER |d OCLCQ |d VAM |d OCLCE |d IDEBK |d OCLCQ |d DKDLA |d CCO |d E7B |d TFW |d OCLCQ |d ORU |d FVL |d OCLCQ |d OCLCF |d OCLCO |d OCLCQ |d NLGGC |d YDXCP |d EBLCP |d OCLCQ |d N$T |d OCLCQ |d AZK |d LOA |d OCLCO |d OCLCA |d MOR |d PIFBR |d ZCU |d OCLCQ |d MERUC |d OCLCQ |d OCLCO |d OCLCA |d U3W |d BUF |d OCLCO |d STF |d WRM |d ICG |d VT2 |d AU@ |d OCLCO |d OCLCQ |d MERER |d OCLCO |d CUY |d OCLCO |d OCLCA |d WYU |d TKN |d DKC |d OCLCQ |d UX1 |d CEF |d HS0 |d UWK |d ADU |d OCLCQ |d UKAHL |d UKCRE |d OCLCQ |d OCLCO |d SFB |d OCLCQ |d REDDC |d OCLCQ |d OCLCO |d OCL |d OCLCQ |d OCLCO |d OCLCL |d SHC |d INARC | ||
| 019 | |a 122385562 |a 176910098 |a 473740134 |a 473950684 |a 568026169 |a 608606981 |a 637335391 |a 637335403 |a 648189482 |a 722554574 |a 728034774 |a 814481322 |a 923276655 |a 961551667 |a 962680946 |a 966234420 |a 975243082 |a 975291885 |a 988417905 |a 991985814 |a 1018074462 |a 1037935260 |a 1038659381 |a 1044657865 |a 1045216232 |a 1045345480 |a 1055312570 |a 1062855816 |a 1081251719 |a 1082494906 |a 1101715719 |a 1103537659 |a 1109056719 |a 1110298296 |a 1112862355 |a 1119121802 |a 1124426321 |a 1125850806 |a 1131960065 |a 1153482964 |a 1156353557 |a 1162251743 |a 1227636549 |a 1228569923 |a 1249238208 |a 1257355257 |a 1290067365 |a 1310445217 |a 1341823040 |a 1424897955 | ||
| 020 | |a 9780309667111 |q (electronic bk.) | ||
| 020 | |a 0309667119 |q (electronic bk.) | ||
| 020 | |a 0309133998 | ||
| 020 | |a 9780309133999 | ||
| 020 | |a 9786610844333 | ||
| 020 | |a 661084433X | ||
| 020 | |z 1280844337 | ||
| 020 | |z 9781280844331 | ||
| 020 | |z 030910386X |q (pbk.) | ||
| 020 | |z 9780309103862 |q (pbk.) | ||
| 029 | 1 | |a AU@ |b 000051318126 | |
| 029 | 1 | |a DEBBG |b BV044108645 | |
| 029 | 1 | |a NZ1 |b 12060713 | |
| 035 | |a (OCoLC)182530367 |z (OCoLC)122385562 |z (OCoLC)176910098 |z (OCoLC)473740134 |z (OCoLC)473950684 |z (OCoLC)568026169 |z (OCoLC)608606981 |z (OCoLC)637335391 |z (OCoLC)637335403 |z (OCoLC)648189482 |z (OCoLC)722554574 |z (OCoLC)728034774 |z (OCoLC)814481322 |z (OCoLC)923276655 |z (OCoLC)961551667 |z (OCoLC)962680946 |z (OCoLC)966234420 |z (OCoLC)975243082 |z (OCoLC)975291885 |z (OCoLC)988417905 |z (OCoLC)991985814 |z (OCoLC)1018074462 |z (OCoLC)1037935260 |z (OCoLC)1038659381 |z (OCoLC)1044657865 |z (OCoLC)1045216232 |z (OCoLC)1045345480 |z (OCoLC)1055312570 |z (OCoLC)1062855816 |z (OCoLC)1081251719 |z (OCoLC)1082494906 |z (OCoLC)1101715719 |z (OCoLC)1103537659 |z (OCoLC)1109056719 |z (OCoLC)1110298296 |z (OCoLC)1112862355 |z (OCoLC)1119121802 |z (OCoLC)1124426321 |z (OCoLC)1125850806 |z (OCoLC)1131960065 |z (OCoLC)1153482964 |z (OCoLC)1156353557 |z (OCoLC)1162251743 |z (OCoLC)1227636549 |z (OCoLC)1228569923 |z (OCoLC)1249238208 |z (OCoLC)1257355257 |z (OCoLC)1290067365 |z (OCoLC)1310445217 |z (OCoLC)1341823040 |z (OCoLC)1424897955 | ||
| 037 | |n Title subscribed to via ProQuest Academic Complete | ||
| 042 | |a dlr | ||
| 050 | 4 | |a RC270.3.T84 |b C36 2007eb | |
| 060 | 4 | |a 2007 G-733 | |
| 060 | 4 | |a QZ 241 |b C2137 2007 | |
| 072 | 7 | |a K |2 bicssc | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.99/4075 |2 22 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Cancer biomarkers : |b the promises and challenges of improving detection and treatment / |c Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment, Institute of Medicine of the National Academies ; Sharyl J. Nass and Harold L. Moses, editors. |
| 260 | |a Washington, D.C. : |b National Academies Press, |c ©2007. | ||
| 300 | |a 1 online resource (xiv, 236 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file | ||
| 504 | |a Includes bibliographical references. | ||
| 505 | 0 | |a Introduction -- Methods, tools, and resources needed to discover and develop biomarkers -- Guidelines, standards, oversight, and incentives needed for biomarker development -- Methods and process needed for clinical adoption and evaluation of biomarker-based diagnostics. | |
| 588 | 0 | |a Print version record. | |
| 520 | |a Many cancer patients are diagnosed at a stage in which the cancer is too far advanced to be cured, and most cancer treatments are effective in only a minority of patients undergoing therapy. Thus, there is tremendous opportunity to improve the outcome for people with cancer by enhancing detection and treatment approaches. Biomarkers will be instrumental in making that transition. Advances in biotechnology and genomics have given scientists new hope that biomarkers can be used to improve cancer screening and detection, to improve the drug development process, and to enhance the effectiveness and safety of cancer care by allowing physicians to tailor treatment for individual patients-an approach known as personalized medicine. However, progress overall has been slow, despite considerable effort and investment, and there are still many challenges and obstacles to overcome before this paradigm shift in oncology can become a reality. | ||
| 506 | |3 Use copy |f Restrictions unspecified |2 star |5 MiAaHDL | ||
| 533 | |a Electronic reproduction. |b [Place of publication not identified] : |c HathiTrust Digital Library, |d 2010. |5 MiAaHDL | ||
| 538 | |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |u http://purl.oclc.org/DLF/benchrepro0212 |5 MiAaHDL | ||
| 583 | 1 | |a digitized |c 2010 |h HathiTrust Digital Library |l committed to preserve |2 pda |5 MiAaHDL | |
| 546 | |a English. | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Tumor markers. | |
| 650 | 0 | |a Cancer |x Diagnosis. | |
| 650 | 0 | |a Cancer |x Treatment. | |
| 650 | 0 | |a Biochemical markers. | |
| 650 | 2 | |a Biomarkers, Tumor | |
| 650 | 2 | |a Biomarkers | |
| 650 | 2 | |a Neoplasms | |
| 650 | 6 | |a Marqueurs tumoraux. | |
| 650 | 6 | |a Cancer |x Diagnostic. | |
| 650 | 6 | |a Cancer |x Traitement. | |
| 650 | 6 | |a Marqueurs biologiques. | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Biochemical markers |2 fast | |
| 650 | 7 | |a Cancer |x Diagnosis |2 fast | |
| 650 | 7 | |a Cancer |x Treatment |2 fast | |
| 650 | 7 | |a Tumor markers |2 fast | |
| 700 | 1 | |a Nass, Sharyl J. | |
| 700 | 1 | |a Moses, Harold L. | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment. | |
| 758 | |i has work: |a Cancer biomarkers (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGygXg6gJyK897jcJJm3HC |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Cancer biomarkers. |d Washington, D.C. : National Academies Press, ©2007 |z 9780309103862 |w (DLC) 2007921549 |w (OCoLC)123441224 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378200 |z Texto completo |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36567821 | ||
| 938 | |a Baker & Taylor |b BKTY |c 42.00 |d .00 |i 030910386X |n 0007224398 |s active | ||
| 938 | |a Baker and Taylor |b BTCP |n BK0007224398 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL3378200 | ||
| 938 | |a ebrary |b EBRY |n ebr10170927 | ||
| 938 | |a EBSCOhost |b EBSC |n 191065 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 84433 | ||
| 938 | |a YBP Library Services |b YANK |n 12905231 | ||
| 938 | |a YBP Library Services |b YANK |n 6013180 | ||
| 938 | |a Internet Archive |b INAR |n cancerbiomarkers0000unse_s5k3 | ||
| 994 | |a 92 |b IZTAP | ||